Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frank Kramer

Showing results (101-110 of 117) with videos related to

Pageof 12
Sort By:
Carcinogenesis|October 11, 2011
Silencing of the Wnt transcription factor TCF4 sensitizes colorectal cancer cells to (chemo-) radiotherapyEmil Kendziorra, Kerstin Ahlborn, Melanie Spitzner, et al.
International Journal of Cancer|August 13, 2013
STAT3 inhibition sensitizes colorectal cancer to chemoradiotherapy in vitro and in vivoMelanie Spitzner, Birte Roesler, Christian Bielfeld, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|March 12, 2025
A patient first perspective of sleep disturbance across therapeutic areas: a systematic literature review of qualitative studiesKyle Riedmann, Sean Gay, Sarah Averill Lott, et al.
Molecular Cancer Research : MCR|August 17, 2017
Chemoradiotherapy Resistance in Colorectal Cancer Cells is Mediated by Wnt/β-catenin SignalingGeorg Emons, Melanie Spitzner, Sebastian Reineke, et al.
British Journal of Cancer|May 21, 2022
Gene-expression profiles of pretreatment biopsies predict complete response of rectal cancer patients to preoperative chemoradiotherapyGeorg Emons, Noam Auslander, Peter Jo, et al.
Clinical Epigenetics|January 9, 2019
The histone methyltransferase DOT1L is required for proper DNA damage response, DNA repair, and modulates chemotherapy responsivenessVijayalakshmi Kari, Sanjay Kumar Raul, Jana Maria Henck, et al.
Heart Failure Reviews|March 24, 2017
Redefining the role of biomarkers in heart failure trials: expert consensus documentFrank Kramer, Hani N Sabbah, James J Januzzi, et al.
Studies in Health Technology and Informatics|January 22, 2022
CARE REGIO - Digital Transformation and Technology in Nursing CareDominik Fuchs, Ann-Kathrin Waibel, Maximilian Karthan, et al.
Digital Biomarkers|October 21, 2020
Real-Life Multimarker Monitoring in Patients with Heart Failure: Continuous Remote Monitoring of Mobility and Patient-Reported Outcomes as Digital End Points in Future Heart-Failure TrialsFrank Kramer, Javed Butler, Sanjiv J Shah, et al.
Circulation. Heart Failure|May 12, 2016
Developing New Treatments for Heart Failure: Focus on the HeartMihai Gheorghiade, Christopher J Larson, Sanjiv J Shah, et al.
Pageof 12

Showing results (101-110 of 117) with videos related to

Sort By:
Pageof 12
Carcinogenesis|October 11, 2011
Silencing of the Wnt transcription factor TCF4 sensitizes colorectal cancer cells to (chemo-) radiotherapyEmil Kendziorra, Kerstin Ahlborn, Melanie Spitzner, et al.
International Journal of Cancer|August 13, 2013
STAT3 inhibition sensitizes colorectal cancer to chemoradiotherapy in vitro and in vivoMelanie Spitzner, Birte Roesler, Christian Bielfeld, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|March 12, 2025
A patient first perspective of sleep disturbance across therapeutic areas: a systematic literature review of qualitative studiesKyle Riedmann, Sean Gay, Sarah Averill Lott, et al.
Molecular Cancer Research : MCR|August 17, 2017
Chemoradiotherapy Resistance in Colorectal Cancer Cells is Mediated by Wnt/β-catenin SignalingGeorg Emons, Melanie Spitzner, Sebastian Reineke, et al.
British Journal of Cancer|May 21, 2022
Gene-expression profiles of pretreatment biopsies predict complete response of rectal cancer patients to preoperative chemoradiotherapyGeorg Emons, Noam Auslander, Peter Jo, et al.
Clinical Epigenetics|January 9, 2019
The histone methyltransferase DOT1L is required for proper DNA damage response, DNA repair, and modulates chemotherapy responsivenessVijayalakshmi Kari, Sanjay Kumar Raul, Jana Maria Henck, et al.
Heart Failure Reviews|March 24, 2017
Redefining the role of biomarkers in heart failure trials: expert consensus documentFrank Kramer, Hani N Sabbah, James J Januzzi, et al.
Studies in Health Technology and Informatics|January 22, 2022
CARE REGIO - Digital Transformation and Technology in Nursing CareDominik Fuchs, Ann-Kathrin Waibel, Maximilian Karthan, et al.
Digital Biomarkers|October 21, 2020
Real-Life Multimarker Monitoring in Patients with Heart Failure: Continuous Remote Monitoring of Mobility and Patient-Reported Outcomes as Digital End Points in Future Heart-Failure TrialsFrank Kramer, Javed Butler, Sanjiv J Shah, et al.
Circulation. Heart Failure|May 12, 2016
Developing New Treatments for Heart Failure: Focus on the HeartMihai Gheorghiade, Christopher J Larson, Sanjiv J Shah, et al.
Pageof 12